TP53 and thyroid cancer: These findings suggest that while activation of the p53-downstream tumor suppressors (e.g., the Cdkn1A and the Bax genes) by NCOR1ΔID is crucial, other p53-independent pathways driven by the oncogenic actions of PV are ongoing to continuously propel thyroid cancer progression.